XML 24 R40.htm IDEA: XBRL DOCUMENT v3.3.0.814
Development, Commercialization and Supply Agreement - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Feb. 26, 2015
Sep. 30, 2015
Sep. 30, 2015
License And Collaboration Agreements [Line Items]      
Licensing revenue   $ 163 $ 538
Eddingpharm      
License And Collaboration Agreements [Line Items]      
Non-refundable up-front received $ 15,000    
Deferred revenue   $ 14,500 $ 14,500
Licensing agreement term     16 years
Eddingpharm | Maximum      
License And Collaboration Agreements [Line Items]      
Additional upfront payment eligible to receive based on development, regulatory and sales Milestone $ 154,000    
Eddingpharm | Up-front Payment      
License And Collaboration Agreements [Line Items]      
Licensing revenue     $ 500